Retatrutide 20mg – Research Peptide

Retatrutide 20mg is a novel, multi-agonist peptide designed to interact with three key metabolic hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.

This triple-agonist mechanism has made Retatrutide a significant focus in research exploring complex metabolic regulation. By simultaneously targeting multiple pathways, researchers are investigating its potential effects on energy balance, nutrient utilization, and metabolic efficiency.

In preclinical and ongoing research models, compounds that engage these pathways have been associated with changes in appetite signaling, energy expenditure, and glucose metabolism. Retatrutide’s unique structure allows for broader receptor interaction compared to single- or dual-pathway peptides, positioning it at the forefront of next-generation metabolic research.

Due to its extended activity profile and multi-target approach, Retatrutide is widely studied in models focused on body composition, metabolic adaptation, and hormone signaling networks.

Key Research Areas:

• GLP-1, GIP, and glucagon receptor interaction studies
• Metabolic regulation and energy balance research
• Appetite signaling pathway models
• Glucose metabolism and insulin-related studies
• Advanced body composition research

Product Specifications:

• Compound: Retatrutide
• Quantity: 20mg per vial
• Form: Lyophilized (freeze-dried) powder
• Purity: High purity (research-grade)
• Storage: Store in a cool, dry place before reconstitution

Important Disclaimer:

This product is intended for research purposes only.